A case report of new onset graves’ disease induced by SARS-CoV-2 infection or vaccine?

World Health Organization, 2020 Garg, 2020, Endocrine involvement in COVID-19: mechanisms, clinical features, and implications for care, Indian J. Endocrinol. Metab., 24, 381, 10.4103/ijem.IJEM_440_20 Mateu-Salat, 2020, SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19, J. endocrinol. invest., 43, 1527, 10.1007/s40618-020-01366-7 Lui, 2021, Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19, The J. Clinic. Endo. Metab., 106, e926, 10.1210/clinem/dgaa813 Brüssow, 2021, COVID‐19: vaccine's progress, Microb. Biotechnol., 10.1111/1751-7915.13818 Dotan, 2021, The SARS-CoV-2 as an instrumental trigger of autoimmunity, Autoimmun Rev, 102792, 10.1016/j.autrev.2021.102792 Murugan, 2021, SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease, Endocrine, 1 Mullur, 2014, Thyroid hormone regulation of metabolism, Physiol Rev, 94, 355, 10.1152/physrev.00030.2013 Pokhrel, 2020 Diana, 2018, Thyrotropin receptor blocking antibodies, Horm Metab Res, 50, 853, 10.1055/a-0723-9023 Cui, 2019, Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis, J Transl Med, 17, 1, 10.1186/s12967-018-1765-3 Vitti, 1995, Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis, J. endocrinol. invest., 18, 857, 10.1007/BF03349833 Geffner, 1992, β-Adrenergic blockade for the treatment of hyperthyroidism, Am J Med, 93, 61, 10.1016/0002-9343(92)90681-Z Ross, 2016, 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis, Thyroid, 26, 1343, 10.1089/thy.2016.0229 Tsatsoulis, 2000, The effect of thyrotoxicosis on adrenocortical reserve, Eur J Endocrinol, 142, 231, 10.1530/eje.0.1420231 Allam, 2021, Thyroid disease and covid‐19 infection: case series, Clinical Case Reports, 9, 10.1002/ccr3.4225 Brancatella, 2020, Subacute thyroiditis after Sars-COV-2 infection, The J. Clinic. Endo. Metab., 105, 2367, 10.1210/clinem/dgaa276 Asfuroglu Kalkan, 2020, A case of subacute thyroiditis associated with Covid-19 infection, J. endocrinol. invest., 43, 1173, 10.1007/s40618-020-01316-3 Ippolito, 2020, SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report, J. endocrinol. invest., 43, 1171, 10.1007/s40618-020-01312-7 Vera-Lastra, 2021, Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants, Thyroid, 10.1089/thy.2021.0142 Watad, 2017, Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity, Front Endocrinol, 7, 150, 10.3389/fendo.2016.00150 Ruiz, 2017, Adjuvants-and vaccines-induced autoimmunity: animal models, Immunol Res, 65, 55, 10.1007/s12026-016-8819-5 Bragazzi, 2020, ASIA syndrome and endocrine autoimmune disorders, Best Pract Res Clin Endocrinol Metabol, 34, 101412, 10.1016/j.beem.2020.101412